Pulse Biosciences Change in Accounts Receivable 2016-2025 | PLSE

Pulse Biosciences change in accounts receivable from 2016 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.

Pulse Biosciences Change in Accounts Receivable 2016-2025 | PLSE

Pulse Biosciences change in accounts receivable from 2016 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$186.1B
Intuitive Surgical (ISRG)$169.7B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.8B
Alcon (ALC)$39.4B
IQVIA Holdings (IQV)$32.4B
DexCom (DXCM)$29.5B
Mettler-Toledo (MTD)$26.8B
STERIS (STE)$24.1B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.9B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$7.9B
Masimo (MASI)$7.6B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B